María
Currás Freixes
Chercheuse jusqu' 2022
Radboud University Nijmegen Medical Centre
Nimega, HolandaPublications en collaboration avec des chercheurs de Radboud University Nijmegen Medical Centre (7)
2023
-
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Nature Communications, Vol. 14, Núm. 1
2019
-
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma
Theranostics, Vol. 9, Núm. 17, pp. 4946-4958
-
Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): A European network for the study of adrenal tumors retrospective study
Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 6, pp. 2367-2374
2018
-
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients
Genetics in Medicine, Vol. 20, Núm. 12, pp. 1652-1662
2015
-
DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers
Clinical Cancer Research, Vol. 21, Núm. 13, pp. 3020-3030
-
Functional and in silico assessment of MAX variants of unknown significance
Journal of Molecular Medicine, Vol. 93, Núm. 11, pp. 1247-1255
-
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
Modern Pathology, Vol. 28, Núm. 6, pp. 807-821